Coldstream Capital Management Inc. Raises Position in Colgate-Palmolive Company $CL

Coldstream Capital Management Inc. grew its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 20.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 54,806 shares of the company’s stock after acquiring an additional 9,184 shares during the period. Coldstream Capital Management Inc.’s holdings in Colgate-Palmolive were worth $4,381,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently modified their holdings of CL. Danica Pension Livsforsikringsaktieselskab bought a new position in Colgate-Palmolive in the 3rd quarter worth $39,821,000. Danske Bank A S bought a new stake in Colgate-Palmolive during the third quarter valued at about $67,363,000. Caitong International Asset Management Co. Ltd purchased a new stake in Colgate-Palmolive in the third quarter worth about $112,000. Advisory Services Network LLC increased its position in Colgate-Palmolive by 25.2% in the third quarter. Advisory Services Network LLC now owns 82,430 shares of the company’s stock worth $6,589,000 after buying an additional 16,602 shares in the last quarter. Finally, Jacobs Levy Equity Management Inc. raised its stake in shares of Colgate-Palmolive by 217.8% in the third quarter. Jacobs Levy Equity Management Inc. now owns 107,404 shares of the company’s stock worth $8,586,000 after buying an additional 73,611 shares during the period. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Performance

Shares of NYSE CL opened at $87.56 on Thursday. The company has a debt-to-equity ratio of 18.82, a quick ratio of 0.54 and a current ratio of 0.83. The company has a market cap of $70.58 billion, a P/E ratio of 33.42, a P/E/G ratio of 4.03 and a beta of 0.28. The firm’s fifty day moving average is $90.85 and its two-hundred day moving average is $83.34. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $99.33.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, January 30th. The company reported $0.95 EPS for the quarter, beating the consensus estimate of $0.91 by $0.04. The business had revenue of $5.23 billion during the quarter, compared to the consensus estimate of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The business’s revenue was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.91 EPS. As a group, analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Monday, April 20th will be given a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a yield of 2.4%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.52. The ex-dividend date is Monday, April 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is 79.39%.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 97,843 shares of Colgate-Palmolive stock in a transaction on Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total transaction of $9,223,659.61. Following the completion of the transaction, the chief financial officer directly owned 55,310 shares of the company’s stock, valued at $5,214,073.70. The trade was a 63.89% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Panagiotis Tsourapas sold 35,000 shares of the business’s stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $94.61, for a total transaction of $3,311,350.00. Following the transaction, the chief operating officer owned 10,415 shares in the company, valued at $985,363.15. This trade represents a 77.07% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 184,683 shares of company stock worth $17,486,693 in the last 90 days. 0.34% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of research analysts have recently weighed in on CL shares. Bank of America lifted their price objective on Colgate-Palmolive from $90.00 to $100.00 and gave the company a “buy” rating in a research report on Monday, February 2nd. Citigroup raised their target price on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a research note on Monday, February 2nd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Colgate-Palmolive in a report on Wednesday, January 21st. Argus reiterated a “hold” rating on shares of Colgate-Palmolive in a research report on Thursday, December 11th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Colgate-Palmolive from $93.00 to $97.00 and gave the stock an “overweight” rating in a research note on Monday, February 2nd. Eleven analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $94.75.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.